Growth Metrics

Gilead Sciences (GILD) Return on Capital Employed Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,370.00
Dec 31, 2025 1,369.00
Sep 30, 2025 1,826.00
Jun 30, 2025 1,997.00
Mar 31, 2025 953.00
Dec 31, 2024 -475.00
Sep 30, 2024 -646.00
Jun 30, 2024 -981.00
Mar 31, 2024 -1,196.00
Dec 31, 2023 -44.00
Sep 30, 2023 226.00
Jun 30, 2023 122.00
Mar 31, 2023 -206.00
Dec 31, 2022 -820.00
Sep 30, 2022 -1,855.00
Jun 30, 2022 -1,957.00
Mar 31, 2022 -2,146.00
Dec 31, 2021 -1,933.00
Sep 30, 2021 -2,520.00
Jun 30, 2021 -3,606.00
Mar 31, 2021 -4,747.00
Dec 31, 2020 -4,611.00
Sep 30, 2020 -5,367.00
Jun 30, 2020 -6,507.00
Mar 31, 2020 -5,194.00
Dec 31, 2019 -5,026.00
Sep 30, 2019 -4,221.00
Jun 30, 2019 -2,625.00
Mar 31, 2019 -1,832.00
Dec 31, 2018 -1,271.00
Sep 30, 2018 -1,099.00
Jun 30, 2018 -839.00
Mar 31, 2018 -523.00
Dec 31, 2017 -138.00
Sep 30, 2017 637.00
Jun 30, 2017 813.00
Mar 31, 2017 860.00
Dec 31, 2016 664.00
Sep 30, 2016 957.00
Jun 30, 2016 1,768.00
Mar 31, 2016 1,641.00
Dec 31, 2015 1,002.00
Mar 31, 2015 1,381.00
Dec 31, 2014 1,133.00
Sep 30, 2014 374.00